2 completed, 1 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
Follow PRT1419: new trials by email Literature Review of PRT1419 trials Research Report on PRT1419
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies PRT1419, Azacitidine, Venetoclax - Acute Myeloid Leukemia, B-cell Non-Hodgkin Lymphoma | Phase 1 | Terminated | Prelude Therapeutics Incorporated | 21 | 2022-03-22 | 2024-01-31 |
| A Study of PRT1419 in Patients With Advanced Solid Tumors PRT1419 - Sarcoma, Melanoma | Phase 1 | Completed | Prelude Therapeutics Incorporated | 26 | 2021-08-11 | 2023-03-15 |
| A Study of PRT1419 in Patients With Relapsed/Refractory Hematologic Malignancies PRT1419 - Multiple Myeloma, Acute Myeloid Leukemia | Phase 1 | Completed | Prelude Therapeutics Incorporated | 16 | 2020-09-28 | 2022-11-15 |
Leukemia, Myeloid, Acute (2) · Myelodysplastic Syndromes (2) · Breast Neoplasms (1) · Esophageal Neoplasms (1) · Head and Neck Neoplasms (1) · Hematologic Neoplasms (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelomonocytic, Chronic (1) · Lung Neoplasms (1) · Lymphoma, B-Cell (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Melanoma (1)
Prelude Therapeutics Incorporated (3)
United States (3)